Excepgen
YC W19 ↗San Francisco, US · 3 employees · 4 known investors
ExcepGen develops biologics, gene therapies, and vaccines using synthetic biology approaches to create therapies that operate outside normal cellular regulation constraints.
Founders & leadership· Y Combinator alumni (W19)
TF
Thomas FolliardinFounder
